73 related articles for article (PubMed ID: 21726903)
41. Changes in serum leptin levels during GnRH agonist therapy.
Douchi T; Kuwahata T; Yoshimitsu N; Iwamoto I; Yamasaki H; Nagata Y
Endocr J; 2003 Jun; 50(3):355-9. PubMed ID: 12940465
[TBL] [Abstract][Full Text] [Related]
42. Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus.
Sozen I; Senturk LM; Arici A
Fertil Steril; 2001 Oct; 76(4):792-6. PubMed ID: 11591415
[TBL] [Abstract][Full Text] [Related]
43. GnRH analogs and uterine artery embolization.
Hutchins FL; Worthington-Kirsch R; Berkowitz RP
J Am Assoc Gynecol Laparosc; 1999 Aug; 6(3):367-8. PubMed ID: 10610208
[No Abstract] [Full Text] [Related]
44. Severe Multiple Sclerosis Manifesting upon GnRH Agonist Therapy for Uterine Fibroids.
Sakurai K; Shinohara K; Imai T; Yamano Y; Hasegawa Y
Intern Med; 2020 Dec; 59(23):3093-3096. PubMed ID: 32759585
[TBL] [Abstract][Full Text] [Related]
45. Circulating monocyte chemoattractant protein-1 in heart transplant recipients with cardiac allograft vasculopathy.
Beaudeux JL; Dorent R; Bernard M; Reagan M; Foglietti MJ; Gandjbakhch I; Cacoub P
Clin Biochem; 2002 Feb; 35(1):77-9. PubMed ID: 11937083
[TBL] [Abstract][Full Text] [Related]
46. Fourteen-year-old girl with recurrent luteal-phase-dependent episodes of high fever.
Yamasaki H; Oki T; Iwamoto I; Douchi T
J Obstet Gynaecol Res; 2011 Aug; 37(8):1166-8. PubMed ID: 21501330
[TBL] [Abstract][Full Text] [Related]
47. Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension.
Madej A; Okopień B; Kowalski J; Haberka M; Herman ZS
Pharmacol Rep; 2005; 57(6):878-81. PubMed ID: 16382212
[TBL] [Abstract][Full Text] [Related]
48. Induced hypoestrogenism increases the arterial resistance index of leiomyomata without affecting uterine or carotid arteries.
Spong CY; Sinow R; Renslo R; Cabus E; Rutgers J; Kletzky OA
J Assist Reprod Genet; 1995 May; 12(5):338-41. PubMed ID: 8520200
[No Abstract] [Full Text] [Related]
49. A novel approach to administration of peptides in women: Systemic absorption of a GnRH agonist via transvaginal ring delivery system.
Kimball AB; Javorsky E; Ron ES; Crowley W; Langer R
J Control Release; 2016 Jul; 233():19-28. PubMed ID: 27130696
[TBL] [Abstract][Full Text] [Related]
50. Severe menses-associated hypertension successfully treated with gonadotropin-releasing hormone agonist.
Laffin LJ; Jafar MS; Bakris GL
J Clin Hypertens (Greenwich); 2017 Nov; 19(11):1202-1203. PubMed ID: 28646567
[TBL] [Abstract][Full Text] [Related]
51. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri.
Davis SR
J Clin Endocrinol Metab; 1997 Feb; 82(2):702-3. PubMed ID: 9024281
[No Abstract] [Full Text] [Related]
52. Decreased Serum Monocyte Chemoattractant Protein1 in Salivary Gland Tumor Patients.
Mardani M; AndishehTadbir A; Khademi B; Melekzadeh M; Vaziri L
Asian Pac J Cancer Prev; 2016; 17(7):3601-4. PubMed ID: 27510015
[TBL] [Abstract][Full Text] [Related]
53. E-selectin, resistin and reactive oxygen species levels in GnRH -agonist and -antagonist protocols in IVF/ICSI: a prospective cohort study.
Siristatidis C; Askoxylaki M; Varounis C; Kassanos D; Chrelias C
J Assist Reprod Genet; 2015 Jun; 32(6):959-67. PubMed ID: 25925352
[TBL] [Abstract][Full Text] [Related]
54. Circulating levels of monocyte chemoattractant protein-1 and interleukin-7 in women who have undergone bilateral salpingo-oophorectomy.
Tani A; Yasui T; Matsui S; Kato T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
J Inflamm Res; 2013; 7():1-7. PubMed ID: 24399882
[TBL] [Abstract][Full Text] [Related]
55. 10(-7) m 17β-oestradiol enhances odonto/osteogenic potency of human dental pulp stem cells by activation of the NF-κB pathway.
Wang Y; Zheng Y; Wang Z; Li J; Wang Z; Zhang G; Yu J
Cell Prolif; 2013 Dec; 46(6):677-84. PubMed ID: 24152244
[TBL] [Abstract][Full Text] [Related]
56. Induction of circulating monocyte chemoattractant protein-1 in women with gonadotropin-releasing hormone agonist.
Matsui S; Yasui T; Uemura H; Yamamoto S; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
J Reprod Immunol; 2011 Aug; 90(2):227-34. PubMed ID: 21726903
[TBL] [Abstract][Full Text] [Related]
57. Changes in insulin sensitivity during GnRH agonist treatment in premenopausal women with leiomyoma.
Matsui S; Yasui T; Tani A; Kunimi K; Uemura H; Yamamoto S; Kuwahara A; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
Clin Chim Acta; 2012 Jun; 413(11-12):960-5. PubMed ID: 22366120
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-7 is associated with monocyte chemoattractant protein-1 and soluble E-selectin levels in peripheral blood of newly post-menopausal women.
Yasui T; Saijo A; Uemura H; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
J Reprod Immunol; 2009 Jul; 81(1):97-102. PubMed ID: 19501916
[TBL] [Abstract][Full Text] [Related]
59. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
